Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

0P3C

Karolinska Development Ab (0P3C)

Karolinska Development Ab
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:0P3C
FechaHoraFuenteTítuloSímboloCompañía
12/06/202405:34UK RegulatoryKarolinska Development’s portfolio company Biosergen gets final approval to test lead candidate BSG005 in patients with invasive fungal infectionLSE:0P3CKarolinska Development Ab
28/05/202401:00UK RegulatoryKarolinska Development invests in BOOST Pharma, expanding its portfolioLSE:0P3CKarolinska Development Ab
16/05/202409:40UK RegulatoryKarolinska Development’s Annual General Meeting 2024LSE:0P3CKarolinska Development Ab
08/05/202402:30UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBCLSE:0P3CKarolinska Development Ab
26/04/202401:00UK RegulatoryInterim Report - January-March 2024LSE:0P3CKarolinska Development Ab
16/04/202401:00UK RegulatoryNotice of Annual General Meeting in Karolinska Development AB (publ)LSE:0P3CKarolinska Development Ab
22/03/202403:30UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBCLSE:0P3CKarolinska Development Ab
22/03/202402:00UK RegulatoryKarolinska Development Annual Report 2023 publishedLSE:0P3CKarolinska Development Ab
14/03/202406:48UK RegulatoryKarolinska Development’s portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 millionLSE:0P3CKarolinska Development Ab
14/03/202405:24UK RegulatoryKarolinska Development’s portfolio company Biosergen publishes prospectus due to rights issue of unitsLSE:0P3CKarolinska Development Ab
06/03/202402:00UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition presents preclinical Parkinson’s data on golexanolone at AD/PDLSE:0P3CKarolinska Development Ab
16/02/202401:00UK RegulatoryYear-end Report - January-December 2023LSE:0P3CKarolinska Development Ab
 Showing the most relevant articles for your search:LSE:0P3C